All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Thu 1981-04-30? to Fri 2025-10-10 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| NVO × |
−31.99%
2025-10-10 |
655.88 TR
2025-10-10 |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Thu 1981-04-30? to Fri 2025-10-10 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| NVO × |
+65,487.56%
+15.71%/yr |
+18.65%/yr
(R2=0.975) |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Thu 1981-04-30? to Fri 2025-10-10 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| NVO × |
$10,000.00
1981-04-30 |
$6,558,755.76
2025-10-10 |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Year | NVO |
|---|---|
| 2025 (YTD) | −31.99% |
| 2024 | −15.94% |
| 2023 | +54.84% |
| 2022 | +22.66% |
| 2021 | +63.52% |
| 2020 | +23.33% |
| 2019 | +28.70% |
| 2018 | −12.12% |
| 2017 | +54.23% |
| 2016 | −36.56% |
| 2015 | +39.39% |
| 2014 | +16.67% |
| 2013 | +15.41% |
| 2012 | +44.09% |
| 2011 | +3.91% |
| 2010 | +79.50% |
| 2009 | +26.99% |
| 2008 | −19.73% |
| 2007 | +57.38% |
| 2006 | +51.05% |
| 2005 | +5.27% |
| 2004 | +34.63% |
| 2003 | +43.97% |
| 2002 | −27.24% |
| 2001 | +14.20% |
| 2000 | +38.73% |
| 1999 | −2.00% |
| 1998 | −7.33% |
| 1997 | +55.11% |
| 1996 | +38.18% |
| 1995 | +45.41% |
| 1994 | −3.54% |
| 1993 | +12.22% |
| 1992 | −0.11% |
| 1991 | +44.56% |
| 1990 | +26.25% |
| 1989 | +30.74% |
| 1988 | +84.65% |
| 1987 | −34.27% |
| 1986 | +13.13% |
| 1985 | +25.00% |
| 1984 | −57.39% |
| 1983 | +28.36% |
| 1982 | +10.17% |
| 1981 | +24.65% |
| Thu 1981-04-30? to Fri 2025-10-10 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| NVO × | −60.03% |
−71.33%
1987-10-19 |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||